Maxime Jouaud

Chief Executive Officer

Major shareholder and member

of the strategic committee

Doctor in Neurosciences and Master 2 in Management and Business Administration.

Maxime is in charge of business development and representation of the company to the different public and private actors that gravitate around InSiliBio.

Rémi Villeneuve

Artistic Director

Master of motion design at the multimedia school and training in 3D modeling.

Rémi is in charge of InSiliBio’s external and internal communication, its social networks, its website. He is also in charge of the realization of educational videos in 3D.

Thomas Benitez

Communication officer

Work-study student in Master co-design & UX.

Thomas works with Rémi on the realization of the educational videos in 3D as well as the publication of the posts on the social networks and the update of the website contents.

Benjamin Chantemargue

Scientific Director

Shareholder and member

of the strategic committee

Doctor in molecular modeling from the University of Limoges and Ph.D. in theoretical chemistry from the University of Palacky in the Czech Republic.

Benjamin is the scientific director of InSiliBio. His skills allow him to lead InSiliBio’s internal research team and to design R&D programs in collaboration with customers.

Mehdi Benmameri

R&D Engineer

Doctor in Computational Chemistry,

Master 1 and 2 Drug Design and Doctor of Pharmacy.

Mehdi is involved in the realization of the research projects by using molecular modeling techniques. Mehdi is involved in the use of molecular modeling techniques. (molecular dynamics, development of adapted computer tools to provide an adequate analysis and a reliable description of the studied molecular process)

Ágota Tóth

R&D Engineer

Doctor in Computational Chemistry, MSc, PhD in Medical Biotechnology

Ágota is working on the realization of different research projects by using molecular modeling techniques, such as molecular dynamics and docking. Ágota is involved in the development of computational tools to adequately describe the studied molecular processes.

Marving Martin

PhD student, CIFRE

Doctor in Pharmacy (Limoges) and Master in Drug Design In Silico (Paris).

Marving is in charge of the research and development of the company’s new « InSiliSkin » service through a university research thesis in partnership with the INSERM P&T laboratory in Limoges.


The shareholders have allowed InSiliBio to start a strong growth thanks to an important initial capital. Now they have the power to vote on significant issues such as approving strategic decisions. Their input and feedback can be valuable in shaping the direction of the company and ensuring that it remains focused on achieving its goals.

Pr Patrick Trouillas

Patrick is a Professor at the University of Limoges (Faculty of Pharmacy). He has been working for more than 20 years at developing of the physical chemical methodologies currently used within InSiliBio. He is the co-founder and the president of the strategic committee of InSiliBio.

Pr Michal Otyepka

Michal is a Professor at the CATRIN Research Institute in Czech Republic (Olomouc). He is the head of CATRIN-RCPTM laboratory and he has been Patrick’s sidekick for years. Together, they bring their scientific expertise and network to InSiliBio.

Jouaud Investissement

The holding company was an important financial support for the creation of the company and today its president accompanies us in the commercial development and the structuring of the company.

Retour en haut